Increased plasma homocysteine after menopause.

[1]  S. Vollset,et al.  The Hordaland Homocysteine Studies , 2001, Lipids.

[2]  J. Loscalzo,et al.  Homocysteine and atherothrombosis. , 1998, The New England journal of medicine.

[3]  E. Giltay,et al.  Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. , 1998, The Journal of clinical endocrinology and metabolism.

[4]  S. Vollset,et al.  Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.

[5]  J. Witteman,et al.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.

[6]  H. Blom,et al.  The effect of sequential three‐monthly hormone replacement therapy on several cardiovascular risk estimators in post‐menopausal women , 1997, Fertility and sterility.

[7]  E. Steyerberg,et al.  Age at menopause as a risk factor for cardiovascular mortality , 1995, The Lancet.

[8]  P. Lønning,et al.  Plasma levels of the atherogenic amino acid homocysteine in postmenopausal women with breast cancer treated with tamoxifen , 2006, International journal of cancer.

[9]  S. Vollset,et al.  Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. , 1995, JAMA.

[10]  H. Blom,et al.  Plasma homocysteine and menopausal status ** , 1995, European journal of clinical investigation.

[11]  H. Blom,et al.  Three Different Methods for the Determination of Total Homocysteine in Plasma , 1995, Annals of clinical biochemistry.

[12]  H. Blom,et al.  Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women , 1994, European journal of clinical investigation.

[13]  M. Secic,et al.  Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. , 1994, Clinical chemistry.

[14]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[15]  P. Ueland,et al.  Total homocysteine in plasma or serum: methods and clinical applications. , 1993, Clinical chemistry.

[16]  A. Andersson,et al.  Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma. , 1992, Scandinavian journal of clinical and laboratory investigation.

[17]  B. Hultberg,et al.  Decreased serum homocysteine in pregnancy. , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[18]  M. Malinow,et al.  Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives. , 1992, Atherosclerosis.

[19]  M. Malinow,et al.  Population variation and genetics of plasma homocyst(e)ine level , 1992, Clinical genetics.

[20]  A. Isaksson,et al.  Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status , 1992, European journal of clinical investigation.

[21]  G. Boers,et al.  Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study. , 1992, Contraception.

[22]  P. Ueland,et al.  Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. , 1989, The Journal of laboratory and clinical medicine.

[23]  H. Blom,et al.  Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease , 1988, European journal of clinical investigation.

[24]  W. Willett,et al.  Menopause and the risk of coronary heart disease in women. , 1987, The New England journal of medicine.

[25]  S. S. Kang,et al.  Total homocyst(e)ine in plasma and amniotic fluid of pregnant women. , 1986, Metabolism: clinical and experimental.

[26]  K.,et al.  Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. , 1986, The Journal of clinical investigation.

[27]  J. Hardebo,et al.  Folic acid responsive postmenopausal homocysteinemia. , 1985, Metabolism: clinical and experimental.

[28]  G. Boers,et al.  Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. , 1983, The Journal of clinical investigation.

[29]  T. Grove.  Effect of reagent pH on determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium. , 1979, Clinical chemistry.

[30]  A M de Bruyn,et al.  Cholesterol determinations. A comparative study of methods with special reference to enzymatic procedures. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[31]  W. Kannel,et al.  Menopause and Risk of Cardiovascular Disease: The Framingham Study , 1976 .

[32]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[33]  R. Morfin,et al.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. , 1970, Journal of lipid research.